NHE1-KD in primary AML with FLT3-ITD and RAS mutations (Supplementary Fig. S2D) significantly suppressed in vitro growth (Fig. 3E), lowered pHi (Fig. 3F), and induced apoptosis (Fig. 3G) compared with samples without these mutations. This evidence concerns the gene FLT3 and acute myeloid leukemia.